Swedbank
IONS icon

Swedbank’s Ionis Pharmaceuticals IONS Stock Holding History

Swedbank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.59M Buy
95,666
+63,413
+197% +$4.77M 0.01% 543
2026
Q1 		$2.42M Buy
32,253
+5,000
+18% +$395K ﹤0.01% 623
2025
Q4 		$2.16M Buy
+27,253
New +$2.05M ﹤0.01% 628
2025
Q1 		– Sell
-124,237
Closed -$4.34M – 701
2024
Q4 		$4.34M Sell
124,237
-5,136
-4% -$192K 0.01% 564
2024
Q3 		$5.18M Hold
129,373
– – 0.01% 541
2024
Q2 		$6.17M Sell
129,373
-13,268
-9% -$544K 0.01% 503
2024
Q1 		$6.18M Buy
142,641
+1,643
+1% +$78.3K 0.05% 372
2023
Q4 		$7.13M Buy
140,998
+4,059
+3% +$194K 0.01% 483
2023
Q3 		$6.21M Sell
136,939
-799,809
-85% -$33M 0.01% 479
2023
Q2 		$38.4M Sell
936,748
-24,926
-3% -$958K 0.07% 215
2023
Q1 		$34.4M Sell
961,674
-59,755
-6% -$2.24M 0.07% 222
2022
Q4 		$38.6M Hold
1,021,429
– – 0.08% 205
2022
Q3 		$45.2M Sell
1,021,429
-852
-0.1% -$35.9K 0.11% 174
2022
Q2 		$37.8M Sell
1,022,281
-95,058
-9% -$3.58M 0.09% 195
2022
Q1 		$41.4M Hold
1,117,339
– – 0.08% 217
2021
Q4 		$34.1M Hold
1,117,339
– – 0.06% 258
2021
Q3 		$37.5M Buy
1,117,339
+64
+0% +$2.41K 0.07% 236
2021
Q2 		$44.6M Sell
1,117,275
-3,792
-0.3% -$149K 0.08% 209
2021
Q1 		$50.4M Buy
+1,121,067
New +$62.5M 0.1% 183

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
MFT
Moisand Fitzgerald Tamayo Orlando, Florida $1.02B AUM 21.26% 1-Year Est. Return

Swedbank's IONS Position: Q2 2026 in Review

Swedbank increased its Ionis Pharmaceuticals (IONS) stake by 197% in Q2 2026, buying an estimated $4.77M and bringing the position to 95,666 shares worth $7.59M. The position accounts for 0.01% of the portfolio, ranked #543.

Swedbank first reported a position in IONS in Q1 2021 and has held it in 19 quarters since. The position peaked at $50.4M in Q1 2021. 41 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Swedbank held 95,666 shares of Ionis Pharmaceuticals worth $7.59M as of Q2 2026.
  • Swedbank bought 63,413 Ionis Pharmaceuticals shares in Q2 2026, an estimated $4.77M.
  • Ionis Pharmaceuticals made up 0.01% of Swedbank's portfolio in Q2 2026, its #543 holding.
  • Swedbank first reported a position in Ionis Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • Swedbank's Ionis Pharmaceuticals position peaked at $50.4M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.